Cargando…

Novel Enzyme Replacement Therapies for Neuropathic Mucopolysaccharidoses

Although the advent of enzyme replacement therapy (ERT) for mucopolysaccharidoses (MPS) has paved the way for the treatment for these hereditary disorders, the blood brain barrier (BBB) has prevented patients with MPS involving the central nervous system (CNS) from benefitting from ERT. Therefore, f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Yuji, Okuyama, Torayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014430/ https://www.ncbi.nlm.nih.gov/pubmed/31936354 http://dx.doi.org/10.3390/ijms21020400

Ejemplares similares

Difficulties Associated with Enzyme Replacement Therapy for Mucopolysaccharidoses
por: Yıldız, Yılmaz, et al.
Publicado: (2021)

Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations
por: Parini, Rossella, et al.
Publicado: (2020)

Mucopolysaccharidoses diagnosis in the era of enzyme replacement therapy in Egypt
por: Fateen, Ekram, et al.
Publicado: (2021)

Progression of Cardiovascular Manifestations in Adults and Children With Mucopolysaccharidoses With and Without Enzyme Replacement Therapy
por: Poswar, Fabiano de Oliveira, et al.
Publicado: (2022)

Enzyme replacement therapy interruption in patients with Mucopolysaccharidoses: Recommendations for distinct scenarios in Latin America
por: Solano, MarthaL., et al.
Publicado: (2020)

Impact of intracerebroventricular enzyme replacement therapy in patients with neuronopathic mucopolysaccharidosis type II
por: Seo, Joo-Hyun, et al.
Publicado: (2021)

Aortic Root Dilatation in Taiwanese Patients with Mucopolysaccharidoses and the Long-Term Effects of Enzyme Replacement Therapy
por: Lin, Hsiang-Yu, et al.
Publicado: (2020)

Enzyme replacement therapy attenuates disease progression in two Japanese siblings with mucopolysaccharidosis type VI: 10-Year follow up
por: Furujo, Mahoko, et al.
Publicado: (2017)

Treatment of Neuronopathic Mucopolysaccharidoses with Blood–Brain Barrier-Crossing Enzymes: Clinical Application of Receptor-Mediated Transcytosis
por: Sonoda, Hiroyuki, et al.
Publicado: (2022)

Mucopolysaccharidoses in northern Brazil: Targeted mutation screening and urinary glycosaminoglycan excretion in patients undergoing enzyme replacement therapy
por: Viana, Gustavo M., et al.
Publicado: (2011)

Diagnosis of Mucopolysaccharidoses
por: Kubaski, Francyne, et al.
Publicado: (2020)

ENT and mucopolysaccharidoses
por: Bianchi, Pier Marco, et al.
Publicado: (2018)

Glaucoma in mucopolysaccharidoses
por: Kong, Weijing, et al.
Publicado: (2021)

Mucopolysaccharidoses type I gene therapy
por: Hurt, Sarah C., et al.
Publicado: (2021)

Pentosan Polysulfate: A Novel Therapy for the Mucopolysaccharidoses
por: Schuchman, Edward H., et al.
Publicado: (2013)

Cathepsins in the Pathophysiology of Mucopolysaccharidoses: New Perspectives for Therapy
por: De Pasquale, Valeria, et al.
Publicado: (2020)

New treatments for the mucopolysaccharidoses: from pathophysiology to therapy
por: Fecarotta, Simona, et al.
Publicado: (2018)

Gene Therapy for Neuronopathic Mucopolysaccharidoses: State of the Art
por: de Castro, María José, et al.
Publicado: (2021)

Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical Data
por: Giugliani, Roberto, et al.
Publicado: (2021)

Pathogenesis of Mucopolysaccharidoses, an Update
por: Fecarotta, Simona, et al.
Publicado: (2020)

Genome Editing for Mucopolysaccharidoses
por: Poletto, Edina, et al.
Publicado: (2020)

Anesthesiological risks in mucopolysaccharidoses
por: Moretto, Alessandra, et al.
Publicado: (2018)

Newborn screening in mucopolysaccharidoses
por: Donati, Maria Alice, et al.
Publicado: (2018)

Orthopaedic challenges for mucopolysaccharidoses
por: Borgo, Andrea, et al.
Publicado: (2018)

Ophthalmological Findings in Mucopolysaccharidoses
por: Tomatsu, Shizuka, et al.
Publicado: (2019)

Epidemiology of Mucopolysaccharidoses Update
por: Celik, Betul, et al.
Publicado: (2021)

Bone Biomarkers in Mucopolysaccharidoses
por: Nakamura-Utsunomiya, Akari
Publicado: (2021)

Diagnosis of Mucopolysaccharidoses and Mucolipidosis by Assaying Multiplex Enzymes and Glycosaminoglycans
por: Arunkumar, Nivethitha, et al.
Publicado: (2021)

Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better?
por: Tomatsu, Shunji, et al.
Publicado: (2015)

Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches
por: Fraldi, Alessandro, et al.
Publicado: (2018)

Establishment of Glycosaminoglycan Assays for Mucopolysaccharidoses
por: Tomatsu, Shunji, et al.
Publicado: (2014)

Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses
por: Barone, Rita, et al.
Publicado: (2018)

Mucopolysaccharidoses and the blood–brain barrier
por: Sahin, Onur, et al.
Publicado: (2022)

Enzyme activities of α-glucosidase in Japanese neonates with pseudodeficiency alleles
por: Mashima, Ryuichi, et al.
Publicado: (2017)

Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial
por: Okuyama, Torayuki, et al.
Publicado: (2019)

Divergent developmental trajectories in two siblings with neuropathic mucopolysaccharidosis type II (Hunter syndrome) receiving conventional and novel enzyme replacement therapies: A case report
por: Tomita, Kazuyoshi, et al.
Publicado: (2021)

Evading the AAV Immune Response in Mucopolysaccharidoses
por: Piechnik, Matthew, et al.
Publicado: (2020)

The role of imaging in the skeletal involvement of mucopolysaccharidoses
por: Spina, Vincenzo, et al.
Publicado: (2018)

Advances in the Development of Pharmacological Chaperones for the Mucopolysaccharidoses
por: Losada Díaz, Juan Camilo, et al.
Publicado: (2019)

Oxidative Stress in Mucopolysaccharidoses: Pharmacological Implications
por: Pierzynowska, Karolina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sdsorh0aalb72eob0p9pm22v8h